The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Microbiome’s Role in Inflammatory Arthritis

The Microbiome’s Role in Inflammatory Arthritis

January 1, 2016 • By Arthritis & Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The revolution of culture-independent, high-throughput microbial DNA sequencing, in parallel with the resurgence of interest in further understanding mucosal immunity, has greatly advanced our knowledge of the interplay between our commensual microbes and ourselves. Despite the relative novelty of the human microbiome as an area of study, a substantial body of evidence has accumulated addressing its potential involvement in the pathogenesis of rheumatic disease. This review article explores the available data in animal and human studies, focusing on the role of the intestinal microbiome in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and the spondyloarthritidies (SpA).

You Might Also Like
  • Microbiome Research Provides Clue to Rheumatoid Arthritis
  • Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA
  • Fungal Microbiota Dysbiosis Seen in Inflammatory Bowel Disease

Taken together, the findings of the studies discussed in this article suggest that perturbations in the composition of the intestinal microbiota may be sufficient to trigger arthritis in a variety of murine experimental models of disease. However, potentially joint-protective (or joint-deleterious) properties might also depend on host genetic background and sex. For example, arthritis-susceptible mice show alterations in intestinal microbiota composition and increases in gut permeability when compared with arthritis-resistant controls.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Some interesting findings:

  • Increases in Prevotella correlated with a reduction in reportedly beneficial microbes (i.e., Bactereoides) in patients with new-onset RA.
  • Significant differences between the metagenomes of the cohorts exist and may be functionally relevant as predictors of treatment response. Levels of dihydrofolate reductase (DHFR) are high in metagenome samples rich in Bacteroides, potentially competing with host DHFR for methotrexate (MTX) binding and metabolism. If this is the case, an increase in DHFR-high microbiota in RA patients may help explain why only some RA patients respond adequately to oral MTX.
  • P copri has the ability to dominate the intestinal microbiota, resulting in an increased sensitivity to Dextran sulfate sodium–induced colitis.

In sum, these findings reveal a potential role of the gut microbiome in the pathogenesis of RA. These findings remain correlative and do not represent evidence of causation, but nevertheless prompt further investigations in human disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Read the full article.

Excerpted and adapted from:
Scher JU, Littman DR, Abramson SB. Review: Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheumatol. 2016 Jan;68(1):35–45.

Filed Under: Conditions, Rheumatoid Arthritis, Spondyloarthritis Tagged With: gut microbe, Microbiome, Psoriatic Arthritis

You Might Also Like:
  • Microbiome Research Provides Clue to Rheumatoid Arthritis
  • Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA
  • Fungal Microbiota Dysbiosis Seen in Inflammatory Bowel Disease
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.